Levodopa addiction in non-parkinsonian patients

Neurology

Volumn 61, Issue 10, 2003, Pages 1451-

  Steiner, Israel ^a   Wirguin, Itzhak ^b  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^b BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

CARBIDOPA PLUS LEVODOPA; LEVODOPA; PROMETHAZINE; ROPINIROLE;

ADDICTION; ADULT; AGED; AGITATION; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONFUSION; CONSTIPATION; DIAGNOSTIC ERROR; DIALYSIS; DIARRHEA; DISEASE ACTIVITY; DISEASE COURSE; DRUG EFFECT; DRUG INDICATION; DRUG RESPONSE; DRUG WITHDRAWAL; FEAR; FEMALE; FOLLOW UP; GAIT DISORDER; HALLUCINATION; HEART PALPITATION; HUMAN; MALE; NOCTURNAL HALLUCINATION; PANIC; PARKINSON DISEASE; PATIENT; PHYSICAL EXAMINATION; PRESCRIPTION; PRIORITY JOURNAL; RESTLESS LEGS SYNDROME; RESTLESSNESS; SWEATING; TREATMENT FAILURE;

EID: 0344011462     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.WNL.0000094200.44303.F3     Document Type: Article

References (7)

1. Merims D, Galili-Mosberg R, Melamed E. Is there addiction to levodopa in patients with Parkinson's disease? Mov Disord 2000;15:1014-1016.
2. Vazquez A, Jimenez-Jimenez FJ, Garcia-Ruiz P, Garcia-Urra D. "Panic attacks" in Parkinson's disease. A long-term complication of levodopa therapy. Acta Neurol Scand 1993;87:14-18.
3. Nausieda PA. Sinemet "abusers." Clin Neuropharmacol 1985;8:318-327.
4. Gschwandtner U, Aston J, Renaud S, Fuhr P. Pathologic gambling in patients with Parkinson's disease. Clin Neuropharmacol 2001;24:170-172.
5. Weed MR, Woolverton WL. The reinforcing effects of dopamine D1 receptor agonists in rhesus monkeys. J Pharmacol Exp Ther 1995;275:1367-1374.
6. Koob GF. Drugs of abuse: anatomy, pharmacology and function of reward pathways. Trend Pharmacol Sci 1992;13:177-184.
7. Glassman AH, Koob GF. Psychoactive smoke. Nature 1996;379:677-678.